Key Highlights :
Korean biotechnology companies, including Samsung Biologics, Celltrion and others are heading to Boston to take part in the BIO International Convention, also known as BIO USA, to promote their technologies and products and to seek new business opportunities. The BIO International Convention is one of the largest events for the global bio industry and is organized by the Biotechnology Innovation Organization. This year's event will take place in Boston from Monday to Thursday and will feature more than 9,000 companies from 65 countries.
Korean companies are joining the event in large numbers, with the number of participating companies and organizations rising from 255 to 544. This means Korea will rank second after the U.S. in terms of the number of participating companies and organizations. The central theme of this year's event is Stand Up for Science, which highlights the need for advanced biotechnology to improve the lives of people.
Samsung Biologics will join the event for the 11th straight year and feature the second-largest promotional booth among participating businesses. The company will focus on showcasing the competitiveness of its contract development organization business, which develops medicines, including antibody-drug conjugate drugs and messenger RNA (mRNA) drugs.
Celltrion will showcase its products, particularly Yuflyma, a biosimilar drug for autoimmune disease treatment Humira, which is set to release in the U.S. this year. Lotte Biologics will also make its second appearance to promote plans to have three factories with 360,000-liter drug manufacturing capacities by 2030. SK bioscience, a vaccine developer and manufacturer, will promote its vaccine business capability and business model, which transfers R&D and production to regional governments and partners in overseas countries to build production infrastructure that meets the needs of each region.
The Ministry of Trade, Industry and Energy, together with the Korea Trade-Investment Promotion Agency and the Korea Biotechnology Industry Organization, will run the Korea Pavilion at the exhibition to help 20 Korean biotech companies promote their products to the global market.
BIO USA is an important event for the global bio industry and provides Korean biotechnology companies with a great opportunity to promote their technologies and products and to seek new business opportunities. With the number of Korean companies participating in the event increasing this year, it is expected that many Korean companies will be able to take advantage of this opportunity and make meaningful connections with global partners.